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Abstract Glutamine synthetase is a key enzyme which has
a regulatory role in the brain glutamate pool. According to
previously published proteomic analysis, it was shown that
the expression level of this enzyme is affected by morphine
administration. In our study, we examined the activity of
glutamine synthetase in various structures of rat brain
(cortex, striatum, hippocampus and spinal cord) that are
biochemically and functionally involved in drug addiction
and antinociception caused by morphine. We were not able
to observe any significant changes in the enzyme activity
between morphine-treated and control samples despite
previously reported changes in the expression levels of this
enzyme. These findings stressed the fact that changes
observed in the expression of particular proteins during
proteomic studies may not be correlated with its activity.
Keywords Addiction.Enzymatic activity.Glutamine
synthetase.Morphine.Proteomics
Abbreviations
GS Glutamine synthetase
ICAT Isotope-coded affinity tags
LC MS/MS Liquid chromatography mass spectrometry
MALDI-TOF
MS
Matrix-assisted laser desorption ionisation
time-of-flight mass spectrometry
PSD Postsynaptic density
Introduction
Glutamine synthetase is a key enzyme which has a
regulatory role in the brain glutamate pool. Dysfunctions
of this enzyme and perturbations in the glutamate–gluta-
mine cycle seem to be involved in several neurological
disorders. There is also a growing number of evidence that
gutamatergic transmission is engaged in drug addiction [1].
After reviewing previously published morphinome
studies (proteome in morphine dependence), we found that
glutamine synthetase is one of the proteins whose concentra-
tion in the brain is connected with addiction processes. Morón
et al. [2] found a downregulation of glutamine synthetase in
hippocampal postsynaptic density (PSD) fraction after
morphine administration. Upregulation of this enzyme was
indicated by Prokai et al. [3] during proteomic studies of
cerebral cortex synaptosomes. Kim et al. [4] discovered
phosphorylation of its tyrosine residues. Additionally, we
found publication considering changes in the level of
glutamine synthetase in the spinal cord of morphine-tolerant
mice [5] examined by Western blotting. Additional informa-
tion about the mentioned studies is collected in Table 1.
The fact that changes in glutamine synthetase expression
were linked to morphine administration by three different
methods (isotope-coded affinity tags, (ICAT), 2D gel
electrophoresis and Western blot) in four distinct laborato-
ries seems very appealing: It indicates that quantitative
changes occur in this enzyme during morphine uptake.
Discrepancies between studies and the fact that in our study
[6, 7] we did not observe any changes in the expression
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DOI 10.1007/s00216-010-4244-0of this enzyme also encouraged us to examine the
problem. Proteomic strategy allows the determination of
quantitative changes in protein expression, i.e. the
relative amount of a given protein is measured. In the
case of enzymes, such as glutamine synthetase, the most
important property is their activity, not the amount of
protein. Therefore, in our study, we decided to examine
the activity of glutamine synthetase in various structures
from rat CNS that are involved in drug addiction (cortex,
striatum, hippocampus) and antinociception (spinal cord)
caused by morphine. In the cell, glutamine synthetase
catalyzes the following reaction:
L   Glu þ NHþ
4 þ ATP⟶
Mg 2þ
L   Gln þ ADP þ Pi
If we replaced NH4
+ with NH2O H ,a sar e s u l t ,w eo b t a i n e d
L-γ-glutamyl-hydroxamate.
L   Glu þ NH2OH þ ATP⟶
Mg2þ
L   g   glutamyl
  hydroxamate þ ADP þ Pi:
This compound in the presence of FeCl3 gives a
characteristic colour reaction, which may be measured
colorimetically and enables measuring the enzyme activity
under certain circumstances [8].
Experimental
Animals and treatment
Twenty-five male Wistar rats, weighing between 150 and
200 g, were addicted to morphine via subcutaneous
implantation of pellets containing 75 mg of morphine base.
Twenty control animals received pellets with 0.9% NaCl
instead of morphine. Pellets were implanted under light
ether anaesthesia in the animals’ neck. Animals were
housed in groups of five per cage, under 12:12-h light/dark
cycle. Water and standard food were freely available.
Acute morphine withdrawal, emerging after the adminis-
t r a t i o no fa no p i a t ea n t a g o n i s t ,i sc o n s i d e r e dt ob et h e
physical manifestation of dependence [9]. Therefore, the
progress of addiction was tested with the injection of
naloxone. A dose of 10 nmol naloxone was administrated
to five morphine-treated rats 72 h after pellet implantation
(total volume injected was 5 μl per rat, naloxone
concentration 2 nmol/μl). Since they show immediate
signs of withdrawal, like wet dog shakes, grooming,
washing, etc., they confirmed that the rest of animals
receiving the drug were morphine-dependent. A detailed
description of the procedure may be found here [10]. At
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2940 A. Bodzon-Kulakowska et al.the same time, animals destined for experiments were
decapitated.
Ethical requirements All experiments were performed in
agreement with the respective Polish and European
Communities Council Directives (86/609/EEC) and were
approved by the local ethics committee (permission no.
367/2002).
Tissue excision
Animals were killed by decapitation 72 h after pellet
implantation. Brains were removed from ten control and ten
morphine-dependent rats, and cerebral cortices, striata and
hippocampi were isolated. Due to the prolonged isolation of
brain structures, spinal cords were removed from another
set of ten control and ten morphine-dependent animals.
Tissues were immediately placed separately in Eppendorf
tubes, frozen on dry ice and stored at −80°C prior to
analysis. Structure isolation was not always successful;
therefore, in the final experiments, less than ten replicates
were usually used.
Glutamine synthetase assay
The activity of glutamine synthetase in different structures
from the CNS was measured according to Dennis et al. [11]
with minor modifications [12]. Prior to the final analyses,
the tissue samples were carried out on ice to prevent protein
degradation. Before the experiment, all structures were
weighed. Homogenates of 10% (tissue weight/volume)
were prepared by tissue disruption in water for about 30 s
each using a rotor-stator homogenizer (Pro200, PRO
Scientific Inc., Oxford, CT, USA). Homogenates were
centrifuged and the supernatant collected. The protein
c o n c e n t r a t i o ni ns u p e r n a t a n tw a sm e a s u r e db yt h e
Bradford method [13] using Sigma Aldrich kit. Finally,
samples at a volume of 0.5 ml homogenate at a protein
concentration of 1 mg/ml were prepared. Each sample was
mixed with 0.5 ml of the reaction buffer. Final concen-
trations of the components in the assay were as follows:
44 mM Tris–HCl, 44 mM MgCl2⋅6H2O, 20 mM mercap-
t o e t h a n o l ,1m MD T T ,1 0m MA T P ,5 0m Mg l u t a m a t e ,
0.16% Triton X-100, freshly prepared 100 mM hydroxyl-
amine, 5 μg/ml oligomycin, 1 mM ouabain and an ADP
trap consisting of 10 mM phosphocreatine and 30 U
creatinephosphokinase.
The samples were incubated in water bath at 37°C for
30 min. In the case of the spinal cord, the incubation lasted
for 60 min. At the end of the reaction, 0.5 ml of ferric
chloride stop solution was added to each sample. The
samples were centrifuged (15,000×g,2m i n . ,a m b i e n t
temperature) and the amount of the complex of L-γ-
glutamylhydroxamate and iron(III) chloride was measured
spectrophotometrically at 510 nm (Spectro2000, Labomed
Inc., Los Angeles, CA, USA). The volume of disposable
cuvettes was 0.5 ml.
Synthetic L-γ-glutamylhydroxamate water solutions
(0.5 ml), at desired concentrations, mixed with 0.5 ml
reaction buffer and 0.5 ml of ferric chloride stop
solution, were used for the construction of calibration
curves. Different tissue concentrations and different times
of incubations were used to measure the linearity of the
Fig. 1 Glutamine synthetase
activity (μM min
−1 mg
−1)i n
different structures from the
CNS. Striatum C: 19.5 ± 4.1,
n = 6; M: 21.7 ± 2.6, n =6 ,
p = 0.293. Hippocampus C:
27.8 ± 3.5, n = 9; M: 26.8 ± 3.8,
n =8 ,p = 0.607. Cortex C:
30.8 ± 7.0, n = 9; M: 31.2 ± 4.8,
n =9 ,p = 0.902. Spinal cord C:
10.9 ± 1.8, n = 8; M: 11.2 ± 1.1,
n =9 ,p = 0.710
Activity of glutamine synthetase after morphine administration 2941assay along the timescale and with various protein
concentrations in homogenates.
Results
The activity of glutamine synthetase was measured in
striatum, cortex, hippocampus and spinal cord of the
morphine-dependent and control rats.
To estimate the background of the measurements, we
introduced “blank” samples. Blanks were the samples that
were incubated without homogenates. In such samples,
there was no significant absorbance at 510 nm. This ensures
that during further experiments, only changes in absorbance
caused by the enzyme activity were observed, and they
were not caused by any kind of reaction between the
components of the reaction buffer. Under our assay
conditions, the enzyme activity increased linearly with time
and with protein concentration (data not shown).
Enzyme activity was expressed as micromolars of L-γ-
glutamylhydroxamate produced in time (minutes) with
protein concentration of 1 mg/ml. The mean values for
each group of the samples with their standard deviations are
given in Fig. 1. We were not able to observe any significant
changes in the enzyme activity between morphine-
dependent and control samples from any of the structures
examined.
Therefore, we decided to check whether changing the
sample concentration and incubation time influenced the
results. Five control and five morphine-treated samples
from hippocampus, at a protein concentration of 2 mg/ml,
were taken and incubated for 45 min. In this case, we did
not observe any significant differences either (data not
shown).
Conclusions
In this paper, we have proven that despite the fact that several
previous proteome/morphinome studies have indicated
changes in glutamine synthetase expression or quantity in
cells/tissues/organisms, we did not observe any significant
changes in enzyme activity during our experiments. In the
case of proteomic studies, we have to be aware of the fact that
changes in protein expressions may not be of biological
importance. For example, elevated levels of the enzyme may
not be linked with its increased activity. In fact, the enzyme
may be present in the sample in active as well as in inactive
forms,whichcannotbedistinguishedusingtypical,proteomic
tools. Moreover, statistically significant changes in protein
quantityarenotalwaysconnectedtochangesinanorganism’s
actual state. Thus, proteomics may indicate proteins whose
expression levels were affected by morphine administration,
but their role in the examined occurrence have to be validated
and finally confirmed by other (biochemical and behavioural)
experiments.
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